Fäster bättre med behandlad yta

Add Bio visar positiva resultat med tandimplantat i klinik.

Rapid system for surface hygiene monitoring

The Clean-Trace Surface Testing Instruments are a rapid solution to monitor biological contamination on surfaces in real time to help customers manage their cle...

New automated solution for flexible molecular assays

The fully integrated Qiasymphony is a new automated platform for flexible molecular testing.

Product Specialist at Gradientech AB, Uppsala

Bought a tablet factory – and built his own empire

In 1995, Thomas Eldered was CEO of one of Pharmacia’s factories in the Stockholm area when the Swedish pharmaceutical giant, after a takeover, decided to move i...

Ny vd på Spago Imaging

Andreas Bunge tar över spakarna i medtech-bolaget.

Accelerator får ny vd

Maria Fors tar över spakarna då nuvarande vd:an Andreas Bunge ökar fokus på dotterbolaget Spago.

Bio-Linux goes global

Recently the NEBC Bio-Linux Version 5.0 was released, a one-stop shop for bioinformatics tools in a Linux context.

Multilabel plate readers with luminescence capability

The Enspire Multilabel Plate Reader platform from Perkin Elmer now features sensitive luminescence detection. The new detection capability is primarily aimed at...

Your partnering tool - step by step

Profile, agenda and requests. Those are the basic steps to follow to use the partnering tool for Biotech Forum. Follow our guide to successful partnering!

Enklare RNA preparering med nytt system

NuGen lanserar Applause, ett nytt system för enklare förberedning av RNA.

Mathematician new dean at DTU

On January 1st the Technical University of Denmark, DTU, got a new dean, recruited from the department of Mathematics.

Symphogen buys tumor blocking technology

The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...

Recipharm launches into biologics manufacturing

Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.

Lundbeck divests companies

The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.

Changing e-solutions for clinical trials

Social media and personalized medicine are two factors that will have a great impact on the design and IT-solutions for clinical trials. Unithink is an upcoming...

Martin Bergö: "The Idea is the Thing"

Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recogniz...